Griffith University researchers are tackling the enormous global health problem of malaria through innovative approaches to develop new vaccine and drug candidates. At Griffith’s two leading biomedical research institutes – the Institute for Glycomics and the Eskitis Institute for Drug Discovery – research teams are firmly focused on, and are making progress towards the global […]
Griffith University’s Institute for Glycomics is calling for volunteers to be part of their malaria vaccine trials in 2016 on the Gold Coast.
Griffith University’s Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin as early as next year.
Foremost Australian medical researchers, Professor Mark von Itzstein and Professor Michael Good from Griffith’s Institute for Glycomics have been honoured with election to Fellowship in the Australian Academy of Health & Medical Science.
Researchers at Griffith University’s Institute for Glycomics have been able to induce malaria immunity in animals and are now poised to advance first-stage human trials.
The State Minister for Science, Information Technology, Innovation and the Arts, Mr Ian Walker paid a flying visit to the Gold Coast campus recently to meet with researchers and staff at the Institute for Glycomics. The Minister was greeted by Vice Chancellor and President of Griffith University, Professor Ian O’Connor and Principal Researcher for the […]
Griffith launches human trials for a vaccine against Streptococcus A, the germ that causes rheumatic fever.